16-07-2024
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-t ocilizumab antibodies
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-t ocilizumab antibodies
Articles
Read More
23-04-2024
Domain specific anti-drug antibody or neutralizing antibody assays? Are they both needed to study the clinical
immunogenicity of Abatacept?
Read More
30-09-2023
Temperature Upshifts in Mammalian Cell Culture: A Suitable Strategy for Biosimilar Monoclonal Antibodies?
Read More
10-09-2022
Development and validation of a specific and sensitive method for detection of anti-tocilizumabantibodies in human serum in presence of high concentrations of drug and target.
Read More
20-06-2020
Qualification of a specific, sensitive and target tolerant method to quantitate free tocilizumab in human serum:
Application to clinical studies with intravenous or subcutaneous administration
Read More
Arpit Gupta
HR
Naresh Tatineni
Digital
Aarzoo Parveen
Quality
Vijayender
Engineering
Prabhakar
Product Dev.
Bricks of Biologics, appreciates the contribution and celebrates our people who are the building blocks of Dr. Reddy's Biologics.
Bricks of biologics in general refers to bio-bricks as genetic building blocks which are DNA sequences that can be assembled to create complex biological systems.